MariMed Commences Operations In Newly Expanded Area of Maryland Cultivation Facility
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) has commenced operations in the newly expanded area of its cultivation and processing facility in Hagerstown, Maryland. This expansion will double the facility's flower capacity, enabling MariMed to meet growing demand for its products in the state. The company plans to fill all nine new grow rooms with plantings over the next two months, with the first harvest expected to be ready for sale in Q4 2024.
CEO Jon Levine emphasized the importance of increasing flower production capacity in Maryland, a high-growth adult-use market. In addition to the expanded cultivation facility, MariMed operates a GMP-certified kitchen in Hagerstown and a Thrive Wellness Dispensary in Annapolis, offering products from its award-winning brand portfolio.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) ha avviato le operazioni nella nuova area ampliata del suo impianto di coltivazione e lavorazione a Hagerstown, Maryland. Questa espansione doppierà la capacità di fiori dell'impianto, consentendo a MariMed di soddisfare la crescente domanda dei suoi prodotti nello stato. L'azienda prevede di riempire tutte e nove le nuove stanze di coltivazione con piantagioni nei prossimi due mesi, con il primo raccolto atteso per la vendita nel quarto trimestre del 2024.
Il CEO Jon Levine ha sottolineato l'importanza di aumentare la capacità di produzione di fiori nel Maryland, un mercato per adulti in forte crescita. Oltre all'ampliamento dell'impianto di coltivazione, MariMed gestisce una cucina certificata GMP a Hagerstown e un dispensario Thrive Wellness ad Annapolis, offrendo prodotti dal suo portafoglio di brand premiato.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) ha iniciado operaciones en el nuevo área ampliada de su instalación de cultivo y procesamiento en Hagerstown, Maryland. Esta expansión duplicará la capacidad de flores de la instalación, permitiendo a MariMed satisfacer la creciente demanda de sus productos en el estado. La empresa planea llenar las nueve nuevas salas de cultivo con plantaciones en los próximos dos meses, con la primera cosecha esperada para estar lista para la venta en el cuarto trimestre de 2024.
El CEO Jon Levine enfatizó la importancia de aumentar la capacidad de producción de flores en Maryland, un mercado de adultos de alto crecimiento. Además de la instalación de cultivo ampliada, MariMed opera una cocina certificada GMP en Hagerstown y un dispensario Thrive Wellness en Annapolis, ofreciendo productos de su galardonado portafolio de marcas.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD)가 메릴랜드주 해거스타운에 있는 재배 및 가공 시설의 새로 확장된 지역에서 운영을 시작했습니다. 이번 확장은 시설의 꽃 생산 능력을 두 배로 증가시킬 것이며, MariMed가 주에서 자사 제품에 대한 증가하는 수요를 충족할 수 있도록 합니다. 회사는 앞으로 두 달 동안 아홉 개의 새로운 재배실에 식물을 심을 계획이며, 첫 수확은 2024년 4분기 판매를 위해 준비될 것으로 예상됩니다.
CEO Jon Levine은 메릴랜드주에서 꽃 생산 능력 증가의 중요성을 강조했습니다. 확장된 재배 시설 외에도 MariMed는 해거스타운에 GMP 인증 주방과 아나폴리스에 Thrive Wellness 약국을 운영하며, 수상 경력에 빛나는 브랜드 포트폴리오의 제품을 제공합니다.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) a commencé ses opérations dans le nouvel espace agrandi de son installation de culture et de transformation à Hagerstown, Maryland. Cette expansion doublera la capacité de fleurs de l'installation, permettant à MariMed de répondre à la demande croissante pour ses produits dans l'État. La société prévoit de remplir toutes les neuf nouvelles salles de culture avec des plantations au cours des deux prochains mois, la première récolte étant attendue pour la vente au quatrième trimestre 2024.
Le PDG Jon Levine a souligné l'importance d'augmenter la capacité de production de fleurs dans le Maryland, un marché en plein essor pour les adultes. En plus de l'installation de culture élargie, MariMed gère une cuisine certifiée GMP à Hagerstown et un dispensaire Thrive Wellness à Annapolis, proposant des produits de son portefeuille de marques primées.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) hat den Betrieb in dem neu erweiterten Bereich seiner Anbau- und Verarbeitungseinrichtung in Hagerstown, Maryland, aufgenommen. Diese Expansion wird die Blütenkapazität der Einrichtung verdoppeln, was es MariMed ermöglicht, die wachsende Nachfrage nach seinen Produkten im Bundesstaat zu befriedigen. Das Unternehmen plant, alle neun neuen Anbauräume in den nächsten zwei Monaten mit Pflanzen zu füllen, wobei die erste Ernte voraussichtlich im vierten Quartal 2024 zum Verkauf bereit sein wird.
CEO Jon Levine betonte die Bedeutung der Erhöhung der Blütenproduktion im Maryland, einem stark wachsenden Markt für den Erwachsenenkonsum. Neben der erweiterten Anbauanlage betreibt MariMed eine GMP-zertifizierte Küche in Hagerstown und eine Thrive Wellness Apotheke in Annapolis, die Produkte aus ihrem preisgekrönten Markenportfolio anbietet.
- Expansion doubles flower capacity at Maryland facility
- First harvest from new grow rooms expected in Q4 2024
- Increased capacity to meet growing demand in Maryland's adult-use market
- Company operates GMP-certified kitchen and retail dispensary in Maryland
- None.
Seedlings Planed in New Grow Rooms, In Time for Retail and Wholesale Distribution of Products During Fourth Quarter of 2024
NORWOOD, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it recently commenced operations in the newly expanded area of its cultivation and processing facility in Hagerstown, Maryland. The expansion will double the facility’s flower capacity, enabling MariMed to meet the growing demand for its flower, concentrates, and edibles products in the state.
MariMed is on track to fill all nine new grow rooms with new plantings over the next two months. The Company anticipates its first harvest will be ready for sale through both retail and wholesale channels during the fourth quarter of this year.
“We are thrilled to announce the commencement of cultivation operations in the new wing of our cultivation facility in Hagerstown,” said Jon Levine, MariMed’s Chief Executive Officer. “Maryland is a fantastic, high-growth, adult-use market. Increasing flower production capacity in Maryland was one of our strategic priorities and was necessary to meet the growing demand for our products throughout the state.”
In addition to the expanded cultivation facility, MariMed operates a state of the art, GMP-certified kitchen in the Hagerstown facility, and a Thrive Wellness Dispensary in Annapolis, which offers a curated selection of products across its award-winning brand portfolio, including Nature’s Heritage flower and concentrates, Betty’s Eddies fruit chews, Bubby’s Baked soft-baked goods, Vibations hydrating drink mixes, and the full suite of its InHouse branded products.
About MariMed
MariMed Inc, a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies™, Nature’s Heritage™, InHouse™, Bubby’s Baked™, K Fusion™, Kalm Fusion™, and Vibations™. For additional information, visit www.marimedinc.com.
Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007
Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007
FAQ
When will MariMed's expanded Maryland cultivation facility be fully operational?
How much will the expansion increase MariMed's flower capacity in Maryland?
What products does MariMed offer in its Maryland dispensary?
Where is MariMed's expanded cultivation facility located in Maryland?
